Tidal Investments LLC increased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 13.8% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,250 shares of the biotechnology company’s stock after buying an additional 394 shares during the quarter. Tidal Investments LLC’s holdings in Axon Enterprise were worth $1,299,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in the company. Quent Capital LLC increased its position in shares of Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after acquiring an additional 75 shares in the last quarter. Prestige Wealth Management Group LLC boosted its holdings in Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 44 shares during the last quarter. Blue Trust Inc. raised its holdings in shares of Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after purchasing an additional 79 shares during the last quarter. Brooklyn Investment Group bought a new stake in Axon Enterprise in the 3rd quarter worth about $41,000. Finally, Planning Capital Management Corp lifted its position in shares of Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.
Insider Activity at Axon Enterprise
In other news, Director Jeri Williams sold 110 shares of Axon Enterprise stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $400.00, for a total value of $44,000.00. Following the completion of the sale, the director now directly owns 1,934 shares in the company, valued at $773,600. The trade was a 5.38 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, President Joshua Isner sold 20,000 shares of the stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the transaction, the president now owns 208,166 shares in the company, valued at approximately $126,179,820.90. This trade represents a 8.77 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 102,251 shares of company stock valued at $51,140,606. 6.10% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
Check Out Our Latest Report on AXON
Axon Enterprise Price Performance
Shares of NASDAQ:AXON opened at $609.96 on Thursday. The company has a market capitalization of $46.51 billion, a PE ratio of 157.61, a PEG ratio of 14.19 and a beta of 1.01. The business has a fifty day moving average price of $551.82 and a 200-day moving average price of $412.77. Axon Enterprise, Inc. has a 1-year low of $241.72 and a 1-year high of $698.67. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
- Five stocks we like better than Axon Enterprise
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- 3 Warren Buffett Stocks to Buy Now
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.